recent pharma news Archives - DelveInsight

recent pharma news

pharma-happenings-for-merck-abbvie-incyte-aprea-eisai
Merck’s Keytruda Approval; Abbvie’s Venetoclax; Aprea’s Eprenetapopt; CRL to Incyte’s Retif...

FDA Approves Keytruda in Both Adjuvant and Neoadjuvant Setting in High-Risk Early-Stage TNBCIn July 2021, the US FDA approved pembrolizumab (Keytruda) for high-risk, early-stage triple-negativ...


Latest-pharma-happenings-for-hepion-nimbus-regeneron-bicycle-therapeutics
Hepion aces mid-stage study; Bicycle Therapeutics-Ionis collaboration; Nimbus raises $105M; Regen...

Hepion Pharma's NASH drug is set for Phase 2b after clearing the safety barHepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic drugs fo...


Latest-pharma-happenings-for-rallybio-sanofi-eureka-lilly-unity-biotechnology
Unity’s advanced vascular eye disease trial; Rallybio raises $100 M; Sanofi bets over $1B f...

UNITY Biotechnology declares positive data from phase 1 clinical trial of UBX1325 in Advanced Vascular Eye Disease patients UNITY Biotechnology, Inc., a biotechnology company developing t...


recent-pharma-happenings-for-insilico-sanofi-medtronic-blackstone-cellex
Insilico Medicine raises $255M; Sanofi & Translate Bio initiate trial; Medtronic gains expan...

Insilico Medicine raises USD 255 Million for AI drug discoveryInsilico Medicine, a Hong Kong-based global leader in end-to-end artificial intelligence for target discovery, small molecule chem...


recent-pharma-happenings-for-mallinckrodt-rayzebio-vectory-umoja
Mallinckrodt earns FDA nod for skin therapy; RayzeBio secures $108M; VectorY raises $38M; Umoja b...

Mallinckrodt earns FDA nod for regenerative skin therapy for burnsMallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns. The company said regenerat...


recent-pharma-news-updates-for-biogen-novo-nordisk-bluebird-bio
Biogen’s Alzheimer’s Drug; FDA approval to Novo Nordisk’s Wegovy; Bluebird’s Gene Therapy

Verdict for Biogen’s Long-Awaited Alzheimer’s Drug Is Finally Here  The USFDA finally gave approval to eagerly-anticipated Biogen’s Drug Aducanumab for the treatment of Alzheimer’s d...


recent-pharma-happenings-for-pfizer-abcellera-sarepta-eli-lilly
Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II;...

Pfizer suffers a DMD delay and halts BCMA trials amid safety woes Pfizer has paused after seeing three cases of peripheral neuropathy in an early-stage study, enrollment in a critical ana...


recent-pharma-biotech-news-updates-happenings-for-abbott-biogen-eli-lilly-arch-oncology
Arch Oncology scores $105M; Abbott’s new coronary imaging platform; Lilly scraps IL-23 psoriasis ...

Arch Oncology scores USD 105 Million for anti-CD47 med in solid tumors, multiple myelomaArch Oncology scored USD 105 million from new and old backers to expand the drug’s journey through the c...


recent-pharma-biotech-lifescience-healthcare-news-updates-for-vertex-virta-kalvista-ovid-crispr-therapeutics
Vertex leads in CRISPR Therapeutics deal; Update for Phase 2 clinical trial of KVD824; Ovid dumps...

Vertex leads in CRISPR Therapeutics partnership with USD 900 Million upfrontVertex has boosted a deal with CRISPR Therapeutics to USD 900 million upfront as the companies compete against blueb...


recent-pharma-happenings-for-recursion-repertoire-cequr-eli-lilly
Lilly’s Retevmo shows promise; CeQur tanks up on $110M in funding; Repertoire secures $189M; Recu...

Lilly’s RET inhibitor Retevmo exhibits early promise in new cancer typesThe phase 1/2 LIBRETTO-001 trial enrolled 32 patients with 12 unique RET fusion-positive advanced cancer types, comprisi...


Editor's Pick
Discover How Learning Disability Treatment Landscape is Evolving with the Eme...

A Learning Disability (LD) is a neurological condition resulting from genetic and neuro...

Development of Gene Therapies in Dermatology

What is Gene Therapy and Is the Skin Suitable for Gene Therapy? Since its first discove...

Mapping the Increasing Burden of Heart Failure: What Does it Bring for Health...

Heart failure (HF), also referred to as Congestive Heart failure (CHF), is a condition ...

Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.